End Stage Renal Disease Clinical Trials in New York, New York

3 studies are recruiting for end stage renal disease in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease

    The goal of this clinical trial is to learn if a GalKO Porcine Thymokidney can maintain renal function, without the need for dialysis, after transplantation into adult subjects with End Stage Renal Disease.

    Stage
    Phase 1
    Ages
    18 to 70
    Site
    NYU Langone Health, New York, New York
    Locations
    2 in total
    Run by
    Xeno Holdings (US), LLC dba ChoironeX

    See if you can join NCT07696962 on ClinicalTrials.gov

  2. Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

    The aim of this study is to evaluate DCR-PHXC in participants with PH1 and severe renal impairment, with or without dialysis.

    Stage
    Phase 2
    Ages
    Any age
    Site
    Clinical Trial Site, New York, New York
    Locations
    18 in total
    Run by
    Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

    See if you can join NCT04580420 on ClinicalTrials.gov

  3. Safety and Efficacy of Empagliflozin in Hemodialysis

    A 12-week, phase II, randomized, double-blind, placebo-controlled, multi-center study to assess the safety, tolerability, and preliminary efficacy of empagliflozin versus placebo among patients initiating hemodialysis (n=60) for the treatment of end-stage kidney disease.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    NYU Langone Health, New York, New York
    Locations
    2 in total
    Run by
    NYU Langone Health

    See if you can join NCT05786443 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.